# Adam Feuerstein
פרקי פודקאסט מובילים
מְעוּדכָּן:
adam feuerstein is an American journalist and columnist covering the biotechnology sector.
== Education ==
adam feuerstein completed a bachelor's degree in political science at Emory University.
== Career ==
adam feuerstein is a senior writer at STAT covering the intersection of biotech and Wall Street, and a co-host of "The Readout LOUD" podcast.
Would You Step In To Stop Bullying?
After years of building “successful” businesses, raising a big family, and living a life that looked perfect on the outside, we made the most terrifying—and most freeing—decision of our lives: we burned it all down to follow our calling from God.In this faith and purpose inspirational story, Adam …
Episode 162 - November 7, 2025
On this week’s episode, Graig Suvannavejh, Paul Matteis, Brian Skorney, Yaron Werber, Chris Garabedian, and guest Adam Feuerstein open with a discussion on George Tidmarsh’s departure from the FDA and the uncertainty it has caused in the markets. Next, the co-hosts discuss the shifting policies of…
The Year in Biotech and What’s Ahead for 2026
Biotech stocks staged a dramatic turnaround in 2025, with the XBI well outpacing the S&P 500 despite concerns over leadership changes at the U.S. Food and Drug Administration, the Trump administration’s efforts to put constraints on drug pricing, and its broader cuts to health and science agencies…
387: Challenges for a crucial sickle cell treatment and the latest outlook for GLP-1s
On this week’s episode of The Readout LOUD: two starkly different financial outlooks from Novo Nordisk and Eli Lilly, a psychedelics drug from Compass Pathways encountered a roadblock with the Trump White House, and a closer look at why manufacturing problems have slowed the rollout of a crucial s…
390: FDA turmoil, election intrigue, AI, and more
On "The Readout LOUD" this week: Adam Feuerstein, solo. His usual co-hosts Allison DeAngelis and Elaine Chen took some time off, so Adam manned the podcast mic himself.
Adam thought, quite understandably, that our cherished listeners wouldn’t want to hear him drone on for 30 minutes, so he thankf…
Episode 174 - February 27, 2026
On this week’s episode, Tess Cameron, Josh Schimmer, Brian Skorney, and special guest Adam Feuerstein kick off with regulatory updates, including the FDA’s rejection of Atara Biotherapeutics and Pierre Fabre Pharmaceuticals’ cell therapy, Ebvallo -- a therapy that should have been approvable. The …
394: Eli Lilly's deal man, Allogene's off-the-shelf CAR-T, and Merck's Terns buy
On this week’s episode of "The Readout LOUD": Allison DeAngelis is still away, leaving Elaine Chen and Adam Feuerstein to mind the podcasting store. You've been warned.
Eli Lilly’s deal man Jake van Naarden is very, very busy, so what does that mean for biotech and pharma? Speaking of deals, Merc…
Episode 180 - April 17, 2026
On today’s episode, Chris Garabedian, Paul Matteis, Tess Cameron, and special guest Adam Feuerstein kick off with a discussion of the public markets, highlighting the XBI’s post‑pandemic highs, Kailera’s IPO pricing and more than $625 million raised, the opening of the IPO window with multiple fil…
Episode 196 - September 18, 2026
On this week's episode, Josh Schimmer, Eric Schmidt, Paul Matteis, and guest Adam Feuerstein open with the OpenAI/Hugging Face AI agent controversy, debating whether calls for AI regulation reflect genuine safety concern or capital rotating out of biotech into AI. Turning to markets, the group des…
Why Convenience Is Shrinking Masculinity | Adam Feuerstein of The Forge
Send us Fan Mail
Business Community https://www.skool.com/thebusinessnetworkNewsletter https://doing-business-with-a-servants-heart.kit.com/steveramona📖 Quote: “There are some very powerful companies that have figured out how to profit from the passivity of those men.” — Adam Feuerstein
📝Descrip…
מנוע חיפוש PODCAST
אתה יכול להשתמש באתר שלנו כדי לחפש3,829,333פודקאסטים ופודקאסטים196,593,390לפי אנשים, מקומות או נושאים.
השקעה בידע מניבה את התשואה הטובה ביותר, ולכן אני מאזין לפודקאסטים.
‐ Benjamin "Llamacorn" Franklin
